2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children